Arcutis Biotherapeutics, Inc. ARQT Business Segments — Interest Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s business segments — interest income?
- Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — interest income of $2.28M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s business segments — interest income changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s business segments — interest income decreased by 10.3% year-over-year, from $2.54M to $2.28M.
- What does business segments — interest income mean?
- Represents the income earned from cash balances, short-term investments, or other interest-bearing assets held by the segment. This reflects the segment's ability to generate returns on its liquid capital reserves.